(Q36530211)

14 August 2017

1 reference

title

Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines (English)

1 reference

14 August 2017

1 reference

1 reference

3

Bradford D Gessner

1 reference

14 August 2017

Judith E Mueller

1

1 reference

14 August 2017

Raymond Borrow

series ordinal

2

1 reference

14 August 2017

publication date

1 June 2006

1 reference

Expert Review of Vaccines

14 August 2017

published in

1 reference

14 August 2017

volume

5

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

319-336

1 reference

Human immunity to the meningococcus. I. The role of humoral antibodies

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Emergence of meningococcal meningitis caused by W 135 subgroup in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Recent increase in meningitis Caused by Neisseria meningitidis serogroups A and W135, Yaoundé, Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Serogroup W135 meningococcal disease in Hajj pilgrims.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

PCR of cerebrospinal fluid for diagnosis of bacterial meningitis during meningococcal epidemics; an example from Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Manson Lecture. Meningococcal meningitis in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

First report of capsule replacement among electrophoretic type 37 Neisseria meningitidis strains in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Capsule switching of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Azithromycin-induced rash in infectious mononucleosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Emergence of W135 meningococcal meningitis in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Genetics of capsule O-acetylation in serogroup C, W-135 and Y meningococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Molecular epidemiology of meningococci isolated in Niger in 2003 shows serogroup A sequence type (ST)-7 and serogroup W135 ST-11 or ST-2881 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

PCR identification of the group A Neisseria meningitidis gene in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Multilocus sequence typing of Neisseria meningitidis directly from clinical samples and application of the method to the investigation of meningococcal disease case clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Acute bacterial meningitis in children admitted to a rural Kenyan hospital: increasing antibiotic resistance and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Long-acting oily chloramphenicol for meningococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Meningococcal disease and season in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

How contagious are common respiratory tract infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Risk factors for invasive meningococcal disease in southern Queensland, 2000-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Household crowding a major risk factor for epidemic meningococcal disease in Auckland children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Smoking, the environment and meningococcal disease: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Risk factors for meningococcal meningitis in northern Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Group A meningococcal carriage in travelers returning from Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Factors influencing susceptibility to meningococcal disease during an epidemic in The Gambia, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Meningococcal carriage, meningococcal disease and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Neisseria meningitidis: an overview of the carriage state

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Serologic correlates of protection for evaluating the response to meningococcal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Neisseria meningitidis serogroup W-135 carriage among US travelers to the 2001 Hajj.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Naturally-acquired immunity to Neisseria meningitidis group A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Human immunity to the meningococcus. II. Development of natural immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Increased genetic diversity of Neisseria meningitidis isolates after the introduction of meningococcal serogroup C polysaccharide conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

The duality of virulence and transmissibility in Neisseria meningitidis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

A chromosomally integrated bacteriophage in invasive meningococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Neisseria meningitidis W-135 carriage during the Hajj season 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Dose escalation, safety and immunogenicity study of a tetravalent meninogococcal polysaccharide diphtheria conjugate vaccine in toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Serum group a anticapsular antibodies in a Sudanese population immunized with meningococcal polysaccharide vaccine during a group A epidemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

NadA, a novel vaccine candidate of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Antibody Responses to Nasopharyngeal Carriage ofStreptococcus pneumoniaein Adults: A Longitudinal Household Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

Genetic Analysis of Meningococci Carried by Children and Young Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.3.319

21 January 2018

Identifiers

DOI

10.1586/14760584.5.3.319

1 reference

14 August 2017

1 reference